For richer, for poorer, in sickness and in health: The entanglement of science and marketing

Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical industry over the evaluation of its products, its use of opinion leaders, and its accountability to shareholders. Calls for changes to the funding of medical research. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.